Skip to main content Skip to main navigation menu Skip to site footer

Ethics Policies

Emerging Neurologist follows the "Principles of Transparency and Best Practice in Scholarly Publishing"

The journal and editors shall take reasonable steps to identify and prevent the publication of papers where scientific misconduct has occurred, including plagiarism, citation manipulation, and data falsification/fabrication, among others. In the event that the journal or editors are made aware of any allegation of misconduct relating to a published article, COPE’s guidelines will be followed in dealing with allegations.


Authors must reference all relevant sources and identify if they are re-using text or material previously published by themselves or third parties. Source and possible permission should be sought and disclosed whenever material that has already been published is re-used. In the lack of such disclosure and permission, publishing an article that reproduces previously published work in whole or in part is an act of scientific misconduct whether it involves one's own work or third parties’ work.

Emerging Neurologist uses a plagiarism detection software to check the originality of the submitted work. Any submissions that include external, uncited content will be rejected.

Multiple submissions

When you submit a manuscript to Emerging Neurologist, its content must not significantly overlap with any other papers from you or your co-authors’ groups that are currently in evaluation or in the press of another journal. However, Emerging Neurologist supports the posting of preprints; see Self-archiving.

Redundant/serial publication

Redundant (duplicate) publication consists in repeated publication of data or ideas, with possible slight variations, often with at least one author in common.

Major overlap/redundancy (i.e. based on same dataset with identical findings and/or evidence that authors have sought to hide redundancy, for example, by changing title or author order or not referring to previous papers) will be considered scientific fraud, and result in immediate rejection of the manuscript.

Only minor overlap, or legitimate repetition or re-analysis (e.g. subgroup analysis/extended follow-up/repeated methods) may be accepted: however authors must declare any potentially overlapping publications and cite them.

Translations are accepted but must refer to the original publication.

Falsification/fabrication of data

Reporting manipulated or fabricated research data is considered a case of misconduct in scientific publishing. Should a manuscript include such data, it will be immediately rejected.


The corresponding author is requested to ensure that all contributors to the work are listed as authors and are aware of the content of the article, from submission to publication.

Should any change occur in authorship status (addition, omission, or author order) after manuscript submission, then the corresponding author must provide an explanation to the editor. Letters of agreement from all of the authors of the manuscript (including the author concerned by the change) must be provided.

Submitted manuscripts must include an « Author contribution statement » section with accurate details of all co-authors’ respective contribution, which will appear in the published article.

All co-authors mentioned must have taken an active part in the work: the simple fact of providing material or data not initially intended for the work, of obtaining authorisation (or funding), of having an administrative role is not sufficient to justify the position of co-author. Financing the work as a sponsor does not justify co-authorship. The report of a clinical case does not justify the presence of more than 4 authors. The Editor reserves the right to request justification for co-authorship and to reject a manuscript that does not comply with these rules.

Competing interests

Authors should declare professional or personal potentially competing interests that might interfere with an objective presentation of their work. For this purpose, all authors are requested to fill in a disclosure agreement form. The ICMJE Disclosure of Interest form will be used.

Editors and referees must also bring to the journal’s knowledge, possible conflicts of interest that may affect their interpretation or judgement of a submitted paper.

As stated in the Rules for Submission of Articles to Biomedical Journals, proposed by the International Committee of Medical Journal Editors (ICMJE, 2019), patients' right to privacy prohibits publication of articles without informed consent. No information should identify patients, neither in text or photos, nor in an indirect manner (descriptions of individual case histories, photos, X-rays, genetic pedigrees…).

In the case of articles reporting on research involving human subjects, the authors must specify their protocol’s compliance with the ethical rules set up by the responsible Ethics Committee (in France, the Comité Consultatif National d'Éthique, CCNE) and by the Declaration of Helsinki of the World Association of Physicians (WMA) revised in 2013. Unless written consent is obtained from the patient, identifying details must be removed before submission of the article (including illustrations and videos). This requirement also applies when a report involves deceased persons.

Should consent from a patient be requested, authors of the articles concerned must attest that the relevant form has been signed by the patient or a proxy.

The journal does not collect the signed patient forms: authors should attest that the original of the signed form is held by the treating institution.

Published by
Fédération Internationale des Jeunes Neurologues Francophones
Hosted and sponsored by